Page last updated: 2024-08-21
benzydamine and am 251
benzydamine has been researched along with am 251 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Avvisati, R; Badiani, A; Malavasi, E; Marinelli, S; Meringolo, M; Stendardo, E | 1 |
Other Studies
1 other study(ies) available for benzydamine and am 251
| Article | Year |
|---|---|
Intravenous self-administration of benzydamine, a non-steroidal anti-inflammatory drug with a central cannabinoidergic mechanism of action.
Topics: Administration, Intravenous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Benzydamine; Cocaine; Dopamine Uptake Inhibitors; Excitatory Postsynaptic Potentials; Glutamic Acid; Heroin; Long-Term Synaptic Depression; Narcotics; Neural Pathways; Nucleus Accumbens; Piperidines; Prefrontal Cortex; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Self Administration; Synaptic Transmission | 2018 |